Clinical Trial Update: A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating DSP107 in combination with atezolizumab vs fruquintinib as a treatment for colorectal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• DSP107
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Kahr Bio Australia Pty Ltd | Conditions: Colorectal Cancer | Phase 2 | Status: RECRUITING